Does AREDIA Cause Hyperparathyroidism secondary? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hyperparathyroidism secondary have been filed in association with AREDIA. This represents 3.6% of all adverse event reports for AREDIA.
6
Reports of Hyperparathyroidism secondary with AREDIA
3.6%
of all AREDIA reports
4
Deaths
6
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From AREDIA?
Of the 6 reports, 4 (66.7%) resulted in death, 6 (100.0%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AREDIA. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does AREDIA Cause?
Osteonecrosis of jaw (151)
Pain (128)
Anxiety (122)
Spinal osteoarthritis (114)
Osteoarthritis (113)
Dyspnoea (107)
Arthralgia (102)
Osteomyelitis (95)
Anaemia (89)
Atelectasis (89)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which AREDIA Alternatives Have Lower Hyperparathyroidism secondary Risk?
AREDIA vs ARFORMOTEROL
AREDIA vs ARGATROBAN
AREDIA vs ARGININE
AREDIA vs ARGININE\LYSINE
AREDIA vs ARIMIDEX